Connection

Mark Rubinstein to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Mark Rubinstein has written about Antibodies, Monoclonal, Humanized.
Mark Rubinstein
Connection Strength
0.035
Antibodies, Monoclonal, Humanized
  1. The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine. Cancer. 2018 04 15; 124(8):1650-1659.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.